R, C., D, Z., GW, C., M, Y., A, L., V, F., . . . J, L. (2026). Olanzapine (10 mg vs 5 mg vs 2.5 mg) for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) - a systematic review and network meta-analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 34(8), . https://doi.org/10.1007/s00520-026-10944-z
Chicago Style (17th ed.) CitationR, Chow, et al. "Olanzapine (10 mg Vs 5 mg Vs 2.5 mg) for the Prophylaxis of Chemotherapy-induced Nausea and Vomiting (CINV) - a Systematic Review and Network Meta-analysis." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 34, no. 8 (2026). https://doi.org/10.1007/s00520-026-10944-z.
MLA (9th ed.) CitationR, Chow, et al. "Olanzapine (10 mg Vs 5 mg Vs 2.5 mg) for the Prophylaxis of Chemotherapy-induced Nausea and Vomiting (CINV) - a Systematic Review and Network Meta-analysis." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 34, no. 8, 2026, https://doi.org/10.1007/s00520-026-10944-z.